OUR TECHNOLOGY
A novel approach
to clinical grade
non-invasive wearable CGM
Wizmi uses a patented non-invasive optical sensing system that leverages diffusive spectroscopy, electro-optics, and our proprietary Elements Reduction Technology to accurately read glucose signals.
HOW IT WORKS
Full gain. No pain.
Wizmi’s novel approach starts with a different data source. Using our proprietary bio-optical sensor, it captures glucose signals directly from the vein. Traditional CGMs measure glucose in interstitial fluid, which naturally lags behind blood glucose changes.
Fast, accurate glucose insights — without inserting a needle.
Proprietary & patented technology
Accurate data, 24/7
Medical grade accuracy. Continuous monitoring.
Set-it-and-forget-it
Completely needle-free. Adjustable band size.
Proprietary bio-optical sensor
Superior signal-to-noise ratio.
Zero disposables
No sensors to replace every 10–15 days.
Metabolic insights
Rich user data via mobile app.
Universal applicability
Works accurately across all skin tones.
20+